Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Change in Accured Expenses (2023 - 2026)

Cresco Labs filings provide 4 years of Change in Accured Expenses readings, the most recent being -$7.6 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 154.76% to -$7.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$12.9 million, a 430.3% decrease, with the full-year FY2025 number at $8.6 million, up 150.94% from a year prior.
  • Change in Accured Expenses hit -$7.6 million in Q1 2026 for Cresco Labs, down from $10.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $20.1 million in Q1 2023 to a low of -$20.5 million in Q4 2024.
  • Median Change in Accured Expenses over the past 4 years was -$5.2 million (2024), compared with a mean of $913230.8.
  • Biggest five-year swings in Change in Accured Expenses: surged 301.51% in 2025 and later crashed 154.76% in 2026.
  • Cresco Labs' Change in Accured Expenses stood at -$11.5 million in 2023, then plummeted by 77.9% to -$20.5 million in 2024, then soared by 151.87% to $10.6 million in 2025, then crashed by 171.8% to -$7.6 million in 2026.
  • The last three reported values for Change in Accured Expenses were -$7.6 million (Q1 2026), $10.6 million (Q4 2025), and -$5.3 million (Q3 2025) per Business Quant data.